1383 Preclinical characterization of D3L-002, a novel cancer immunotherapy bispecific antibody that elicits potent anti-tumor efficacy via co-blocking TIGIT and PVRIG

1383 Preclinical characterization of D3L-002, a novel cancer immunotherapy bispecific antibody that elicits potent anti-tumor efficacy via co-blocking TIGIT and PVRIG

Bibliographic Details
Main Authors:	Jia Wang, George Chen, Xiaofeng Yang, Zhiqiang Zheng, Zhiqiang Chen, Haopeng Rui, Baotian Yang, Jingtao Lu, Peggy Wu, Janet Chen, Allison Wang
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

473 LAE113, a novel TIGIT/PVRIG bispecific antibody for the treatment of cancer
by: Yan Chen, et al.
Published: (2023-11-01)

485 TIGIT/PVRIG humanized mice-an idea model for studying anti-PVRIG antibodies
by: Xiang Gao, et al.
Published: (2023-11-01)

479 Fc-competent fully human anti-TIGIT blocking monoclonal antibodies demonstrated potent anti-tumor efficacy in preclinical models
by: Xin Zhang, et al.
Published: (2023-11-01)

PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model
by: Songlin Mu, et al.
Published: (2022-05-01)

Development of a bispecific antibody targeting PD-L1 and TIGIT with optimal cytotoxicity
by: Zhenwei Zhong, et al.
Published: (2022-10-01)

PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia
by: Jessica Li, et al.
Published: (2020-11-01)

A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody
by: Tongcheng Dai, et al.
Published: (2024-05-01)

TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity
by: Paloma Riquelme, et al.
Published: (2018-07-01)

575 Preclinical characterization of LAE111, a potent anti-LILRB1/LILRB2 antagonist bispecific antibody
by: Rong Wu, et al.
Published: (2023-11-01)

An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models
by: Xin Chen, et al.
Published: (2022-02-01)

تحلیل صادرات محصولات شیلاتی ایران (1393-1383)
by: افشین عادلی
Published: (2020-02-01)

The Role of Monetary Policy in Iran’s Economy (1338-1383)
by: Fariba Moslehi
Published: (2006-06-01)

P002 (0061) DEVELOPMENT OF AN α-CD30 BISPECIFIC ANTIBODY IMMUNOTHERAPY FOR HODGKIN LYMPHOMA
Published: (2018-10-01)

TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma.
by: Qinghong Li, et al.
Published: (2024-01-01)

A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma
by: Huaikai Shi, et al.
Published: (2025-02-01)

Survey of Susceptibility of Cockroaches To Pyrethroids Insecticides in sari Hospital in 1383
by: A.A. Enayati, Ph.D, et al.
Published: (2007-01-01)

Vidal (Ben) Saúl Satorre, copista hebreo (1383-1411)
by: Asunción Blasco Martinez, et al.
Published: (1991-06-01)

A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models
by: Urara Tomita, et al.
Published: (2024-03-01)

TIGIT in cancer immunotherapy
by: Joe-Marc Chauvin, et al.
Published: (2020-10-01)

Radiosynthesis and Preclinical Evaluation of Bispecific PSMA/FAP Heterodimers for Tumor Imaging
by: Kongzhen Hu, et al.
Published: (2022-03-01)

کلیشه های جنسیتی سریال های تلویزیونی ایرانی سال 1383
by: سهیلا صادقی فسایی, et al.
Published: (2005-11-01)

4322 Structure-guided design of the TIL1383I T cell receptor
by: Jesus Alonso, et al.
Published: (2020-06-01)

Las Definiciones de la Orden de Calatrava, 1383 - 1418.
by: Joseph F. O'callaghan
Published: (1996-01-01)

Summary of a workshop on preclinical and translational safety assessment of CD3 bispecifics
by: Cris Kamperschroer, et al.
Published: (2020-01-01)

TIGIT, a novel immune checkpoint therapy for melanoma
by: Wei Tang, et al.
Published: (2023-07-01)

Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies
by: Yizhou Zhang, et al.
Published: (2024-12-01)

عوامل جمعیتی موثر بر باروری زنان یزد در سال 1383
by: دکتر صمد کلانتری, et al.
Published: (2005-07-01)

From Algarve to the Empire and the entitlemente: enoblement strategies in the House of Quarteira (1383-1599)
by: Nuno Vila-Santa
Published: (2018-07-01)

پویایی طلاق در ایران با تأکید بر دوره 1393-1383
by: حسین ملتفت, et al.
Published: (2021-02-01)

TIGIT regulates CD4+ T cell immunity against polymicrobial sepsis
by: Xuexin Zhong, et al.
Published: (2024-03-01)

Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis
by: Chuiwen Deng, et al.
Published: (2020-07-01)

Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
by: Hong-fen Guo, et al.
Published: (2021-09-01)

Self-delivery of TIGIT-blocking scFv enhances CAR-T immunotherapy in solid tumors
by: Fan Yang, et al.
Published: (2023-06-01)

503 Tumor infiltrating lymphocytes in soft tissue sarcomas upregulate the exhaustion marker TIGIT and are reinvigorated by IL-15 stimulation and TIGIT blockade
by: Shuai Chen, et al.
Published: (2020-11-01)

Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages
by: Ping Ren, et al.
Published: (2023-07-01)

The Function of female representatives in the sixth term of the Islamic Council )1379-1383/2000-2004
by: Nooraldin Nemati
Published: (2023-11-01)

A sociedade política joanina (1383 - 1433): Para uma visáo de conjunto.
by: Armando Luis de Carvalho Homem
Published: (1989-01-01)

بررسی لیشمانیوز جلدی در شهرستان لامرد طی سال‌های 1383-1393
by: ابوبکر جعفرنژاد, et al.
Published: (2017-04-01)

Construction of Novel Bispecific Single-Domain Antibodies (BiSdAbs) with Potent Antiangiogenic Activities
by: Xianglei Liu, et al.
Published: (2020-03-01)

Dynamic Expressions of TIGIT on Splenic T Cells and TIGIT-Mediated Splenic T Cell Dysfunction of Mice With Chronic Toxoplasma gondii Infection
by: Haoran Li, et al.
Published: (2021-08-01)